SCHEMBL23867525

SCHEMBL23867525

Cc1nc(N2CCN(CCO)CC2)nc(Nc2ccc(NC(=O)Cc3cccs3)cc2)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 7/20 0.49
▸ HTR2C P28335 2/20 0.48
▸ SRC P12931 1/20 0.47
▸ POLB P06746 8/20 0.47
▸ RAB9A P51151 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ DRD3 P35462 2/20 0.44
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ BLM P54132 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ CTDSP1 Q9GZU7 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ XBP1 P17861 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ DNMT1 P26358 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30234578 0.89 POLB (0.52) POLBRAB9ASMN1; SMN2NPC1MAPT
SCHEMBL23867477 0.89 POLB (0.52) POLBRAB9ASMN1; SMN2NPC1MAPT
SCHEMBL23867515 0.85 POLB (0.47) HTR2AHTR2CSRCPOLBRAB9A
SCHEMBL23867574 0.85 PYGM (0.53) HTR2AHTR2CSRCDRD3HPGD
SCHEMBL23867479 0.83 POLB (0.49) POLBRAB9ASMN1; SMN2NPC1MAPT
SCHEMBL23867474 0.82 SRC (0.51) HTR2AHTR2CSRCPOLBRAB9A
SCHEMBL23867514 0.80 POLB (0.50) HTR2ASRCPOLBRAB9ASMN1; SMN2
SCHEMBL23867522 0.76 HTR2A (0.53) HTR2AHTR2CSRCDRD3
SCHEMBL30234726 0.74 POLB (0.51) POLBRAB9ASMN1; SMN2NPC1MAPT
SCHEMBL23867516 0.74 POLB (0.53) POLBRAB9ASMN1; SMN2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback